SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001415889-16-005304
Filing Date
2016-03-25
Accepted
2016-03-25 16:47:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D innv13d_mar2016.htm SC 13D 63230
  Complete submission text file 0001415889-16-005304.txt   64598
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Subject) CIK: 0001411879 (see all company filings)

IRS No.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87796 | Film No.: 161530041
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIO-QUANT, INC. 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO CA 92121
Business Address
Damaj Bassam (Filed by) CIK: 0001478733 (see all company filings)

Type: SC 13D